This post was originally published on this site
Original post: Newswise - Drug and Drug Abuse Scientific Consortium Established by National Institutes of Health Provides Real-Time Risk Assessment of SARS-CoV-2 Variants on Immune Protection
Program employs a coordinated approach and serves as a template for response against rapidly evolving pandemic pathogens